Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects
- PMID: 1906375
- DOI: 10.1097/00002826-199106000-00010
Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects
Abstract
The capability of pravastatin and lovastatin, HMG-CoA reductase inhibitors likely to be taken chronically for hypercholesterolemia, to cross the blood-brain barrier was investigated in normal male volunteers. Lovastatin, which is lipophilic, was detected in cerebrospinal fluid (CSF) at concentrations that may have a pharmacologic effect. Pravastatin, which is hydrophilic, was not detected in CSF. It is concluded that pravastatin may have less potential for causing CNS-related side effects than lovastatin.
Comment in
-
Pravastatin and lovastatin in cerebrospinal fluid.Clin Neuropharmacol. 1993 Dec;16(6):559-60. doi: 10.1097/00002826-199312000-00010. Clin Neuropharmacol. 1993. PMID: 9377592 Clinical Trial. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources